• Update on the LOTS program -- 25 January 2007

• 2007 IPA Annual Review is now available online -- 16 January 2007

• Article Concerning Myozyme® has been posted to CenterWatch (a Clincial Trials Listing Service) -- 12 December 2006

• European Public Assesment report of Myozyme® is available online - 17 August 2006

• The drug label for Myozyme® is now available for patients to review - 09 June 2006

• Letter from IPA and Genzyme concerning LOTS - 09 June 2006

• FDA Approves Genzyme's Myozyme® in United States - 28 April 2006

• European Commission Approves Genzyme's Myozyme® - 03 April 2006

• Update on Genzyme's Pompe Program - 27 February 2006

• Genzyme Responds to the EMEA's 26 Jan. 2006 press release - 31 January 2006

• The EMEA issued a Press Release on their opinion of Myozyme® - 26 January 2006

• Genzyme Provides Update on U.S. Marketing Application for Myozyme® - 17 January 2006

• September 2005 Update on Genzyme's Pompe Program - 15 October 2005

• Genzyme Submits BLA for Myozyme^® for Treatment of Pompe Disease - 29 July 2005

• Update on Genzyme's Pompe Program - 18 July 2005

• Information om Late-onset Screening Study Available - 08 June 2005

• The Preliminary Results from the 1602 trial have been released - 28 April 2005

• Update on Genzyme's Pompe Program - 22 March 2005

• Genzyme Files for European Approval of Myozyme® For Treatment of Pompe Disease - 20 December 2004

• Update on Genzyme's Pompe Program - 20 December 2004

• Summary of the IPA/Genzyme Meeting - 10 October 2004

• Joint IPA/Genzyme Statement announcing the new status of the Expanded Access Programs - 16 August 2004

• Update on Genzyme’s Pompe Program by the IPA Secretariat - 15 June 2004

• Current Status of the the late-onset expanded access program - 22 April 2004

• Updates on the late-onset trial and the expanded access program for late-onset - 07 March 2004

• Genzyme Q and A Session at IPA Conference, 31 October 2003

• Genzyme Press Release on late onset ERT trials and expanded access programme - 10 September 2003

• Joint IPA/Genzyme Update - 8 May 2003

• Genzyme press release on new infantile trials - 19 March 2003

• Joint IPA/Genzyme Statement - 18 February, 2003

• IPA/Genzyme joint statement 17 December 2002

• IPA/Genzyme joint statement 24 September 2002

• IPA/Genzyme joint statement on ERT progress 17 April 2002

• Genzyme and Pharming reach agreement on remaining issues 10 December 2001

• Genzyme acquires Pharming's production plant in Geel, Belgium 30 October 2001

• Genzyme quarterly report shows $17.2 million set aside to ensure continued supply of transgenic alpha glucosidase 18 October 2001

• Genzyme completes deal to acquire Novazyme 27 September 2001

• Genzyme to acquire "certain Pharming assets" 19 September 2001

• Press release : Pharming acts to protect intellectual property 17 September 2001

• Pharming statement on future plans 10 September 2001

• Pharming's receivership woes 24 August 2001

• Genzyme Press Release on continued availability of transgenic enzyme 23 August 2001

• Genzyme/Novazyme statement on future of patients currently on trials 22 August 2001

• Novazyme/Genzyme merge! 7 August 2001

• Novazyme interviewed - 20 May 2001

• Novazyme announce successful results with animal model - 2 April 2001

• Genzyme/Pharming announce new trials imminent - 30 March 2001

• Genzyme's Paul Kaplan interviewed (current state of the art on Genzyme's ERT project)- 29 March 2001

• Genzyme/Pharming announce publication of Duke infantile trial results - 21 March 2001

• Novazyme open new facility as step towards human trials - 7 February 2001

• Novazyme receive Orphan Drug designation for their Pompe's ERT method - 5 October 2000

• Genzyme/Pharming Press Release with Duke trial results - 5 October 2000

• Patient Information from Genzyme - No. 1, 2 October 2000

• Full text of the Patent

• Press Release on Pharming's patent for alpha-glucosidase - 13 September 2000

• Full text of historic publication ERT in The Lancet (you will need to register with the site but it is free) - 29 July 2000

• New kid on the block - Novazyme announces its ERT programme - 6 June 2000

• Press Release on Enzyme Replacement Therapy - 15 March 2000

Back to the IPA Home Page